H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. - NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA

PIID: 75N98026P00992

Signed Date: Jul 9, 2026Effective Date: Jul 13, 2026End Date: Closes in 258 days

Award $

$148K

Vendor

H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.

NAICS

541380

Signed Date

Jul 9, 2026

Key Details

Dollars Obligated

$147,750

Base & All Options

$147,750

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541380 - TESTING LABORATORIES AND SERVICES

Product Service Code

Q301 - REFERENCE LABORATORY TESTING

Extent Competed

NOT COMPETED UNDER SAP

Number of Offers

Place of Performance

BETHESDA, MD

Description

NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA

Context & Analysis

On Jul 9, 2026, Department of Health and Human Services obligated $147,750 to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. for nci - corrective editing of splicing factor mutant myelodysplastic syndromes and chronic myelomonocytic leukemia. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BETHESDA, MD. The contract is scheduled through Jul 12, 2027 — approximately 9 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.